AstraZeneca’s Covid-19 vaccines made by Thailand's Siam Bioscience pass quality testing in Europe and US

BANGKOK (The Nation/ANN): AstraZeneca announced on Sunday (May 9) that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the US.

James Teague, Country President, AstraZeneca (Thailand) Ltd., said: “We have seen a series of significant and promising progress in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , Siam Bioscience , covid-19 , AstraZeneca , vaccine , quality , tests

Next In Aseanplus News
1MDB: MACC to bring back recovered paintings worth over RM120mil
FBM KLCI ends at intraday high, marks 16-month high
5.7-magnitude quake hits waters near Philippines, says GFZ
General Border Committee to meet on Dec 24 to resume Thai-Cambodia ceasefire
US highlights Panama security ties as China-linked canal ports deal stalls
S'wak Deputy Premier wins defamation suit against state DAP chief, awared RM500,000 in damages
Traditional hanfu turn trips into cultural adventures in China
Bhutanese King recalls Thai comfort food and Buddhist warrior spirit in moving Chulalongkorn address
FIFA investigating FAM sec-gen Azman over heritage players saga
Vietnam replaces Trade Minister as leadership review begins

Trending in AseanPlus

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.